Stephen Liu: In 2012, Dr. Julie Brahmer presented the phase I study of immunotherapy in lung cancer

Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown Lombardi, recently shared on X/Twitter:

“In 2012, Dr. Julie Brahmer presented data from the phase I study of nivolumab showing durable responses to immunotherapy in lung cancer. Hear the story behind the trial in tomorrow’s special episode of Lung Cancer Considered, the IASLC podcast, with me and Dr. Narjust Florez.”

Source: Stephen Liu/X